MediPoint: Biopsy Devices - Global Analysis and Market Forecasts - Product Image

MediPoint: Biopsy Devices - Global Analysis and Market Forecasts

  • ID: 2766587
  • Report
  • Region: Global
  • 129 pages
  • GlobalData
1 of 6
Optical and Liquid Biopsies to Compete with Traditional Techniques in $1.16 Billion Market by 2022

FEATURED COMPANIES

  • Argon Medical Devices
  • Boston Scientific
  • C. R. Bard
  • Cook Medical
  • Gallini Medical Devices
  • Hologic
  • MORE
MediPoint: Biopsy Devices - Global Analysis and Market Forecasts

Summary

Cancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient’s body.

The biopsy devices market is segmented by cancer indication and by the type of biopsy procedure performed. Beyond providing a general analysis and forecast for each device segment in different global regions from 2013-2022, this report offers a more detailed approach by assessing the adoption patterns of the different biopsy procedure types for specific cancer indications in specific geographies. This report and forecast focus on the adoption patterns of biopsy guns, fine needle aspiration (FNA) devices, core needle biopsy (CNB) devices, and vacuum-assisted biopsy (VAB) devices, as well as biopsy forceps and punches in the diagnosis of breast, prostate, lung, liver, colorectal, and thyroid cancers.

Highlights

Key Questions Answered

- What are the procedure volumes for different biopsy procedures in different countries? How will the volumes change in the next five years?
- Growth in the biopsy devices market is driven by an increasing number of cancer incident cases. What are the current numbers of cancer diagnosed cases in different geographies? How will the numbers change in the upcoming years?
- Biopsy guns are most frequently used biopsy devices and core needle biopsy devices gain popularity over fine needle aspiration devices. What are the current adoption trends of different types of biopsy device in different geographies? How will the adoption trends evolve in the near future?
- There are various types of biopsy devices and different companies have a different strategic product focus. Who are the leading players in the biopsy devices market?

Reasons to buy

- “What Do Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Argon Medical Devices
  • Boston Scientific
  • C. R. Bard
  • Cook Medical
  • Gallini Medical Devices
  • Hologic
  • MORE
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Overview

2.2 Catalyst

2.3 Related Reports

3 Industry Overview

3.1 Types of Biopsies

3.1.1 Surgical Biopsy

3.1.2 Fine Needle Aspiration

3.1.3 Core Needle Biopsy

3.1.4 Vacuum-Assisted Biopsy

3.2 Market Access to Cancer Screening Programs

3.2.1 Regulation

3.2.2 Biopsy Device Adoption Patterns

3.2.3 Reimbursement Trends

3.2.4 Regulatory Issues/Recalls

3.3 Mergers and Acquisitions/Key Partnerships

3.3.1 Devicor Medical Products Acquires Breast Care Portfolio from Ethicon Endo-Surgery

3.3.2 Argon Medical Devices Acquires Promex Technologies

3.3.3 GTCR Sells Devicor Medical Products

3.3.4 Becton Dickinson Completes Acquisition of CareFusion

3.4 Economic Impact of Cancer Screening and Treatment

3.5 Additional Indications for Biopsy Devices

4 Unmet Needs and Market Opportunity Analysis

4.1 Overview

4.2 Minimise Prostate Biopsy Complications

4.3 More Efficient Screening Tests for Cancer

4.4 More Efficient Screening Guidelines for Thyroid Cancer

4.5 Less Invasive Screening Tests With Better Accuracy

5 Competitive Assessment

5.1 Company Share Analysis

5.1.1 Vacuum-Assisted Biopsy Market Share

5.1.2 Core Needle Biopsy/Fine Needle Aspiration Market Share

5.2 Classification Based on System

5.2.1 Vacuum-Assisted Biopsy Devices

5.2.2 Core Needle Biopsy Devices

5.2.3 Fine Needle Aspiration Devices

5.3 Major Players

5.3.1 Argon Medical Devices

5.3.2 Becton, Dickinson and Company

5.3.3 Boston Scientific

5.3.4 Cook Medical

5.3.5 C. R. Bard

5.3.6 Gallini Medical Devices

5.3.7 Hologic

5.3.8 Leica Biosystems

5.3.9 Stryker

5.3.10 TSK Laboratory

5.3.11 Zamar Care

5.4 Pipeline Products Assessment

5.4.1 Overview

5.4.2 Optical Biopsy

5.4.3 Liquid Biopsy

5.5 Emerging Players

6 Market Outlook

6.1 Biopsy Procedure Trends

6.1.1 Global

6.1.2 US

6.1.3 5EU

6.1.4 Asia-Pacific Region

6.1.5 South America

6.2 Market Drivers and Barriers

6.2.1 Market Drivers

6.2.2 Market Barriers

6.3 Market Outlook by Segment

6.3.1 Fine Needle Aspiration

6.3.2 Core Needle Biopsy

6.3.3 Vacuum-Assisted Biopsy

6.3.4 Biopsy Guns

6.3.5 Biopsy Forceps and Punches

6.4 Market Outlook by Geography

6.4.1 Global

6.4.2 US

6.4.3 France

6.4.4 Germany

6.4.5 Italy

6.4.6 Spain

6.4.7 UK

6.4.8 Japan

6.4.9 Brazil

6.4.10 China

6.4.11 India

7 Appendix

7.1 Bibliography

7.2 Abbreviations

7.3 Report Methodology

7.3.1 Overview

7.3.2 Coverage

7.3.3 Primary Research

7.3.4 Secondary Research

7.3.5 Forecasting Methodology

7.4 Key Opinion Leaders Included in This Study

7.5 About the Authors

7.5.1 Yizhe Xu, MSc, Research Analyst, Medical Devices

7.5.2 Linda Tian, MSc, Managing Analyst, Medical Devices

7.5.3 Tyler Fletcher, Global Head of Medical Devices

7.6 About MediPoint

7.7 About

7.8 Disclaimer

1.1 List of Tables

Table 1: VAB, Global Market Share, 2015

Table 2: CNB/FNA, Global Market Share, 2015

Table 3: Company Profile - Argon Medical Devices

Table 4: Argon Medical Devices, SWOT Analysis, 2016

Table 5: Product Portfolio - Argon Medical Devices

Table 6: Company Profile - BD

Table 7: BD, SWOT Analysis, 2016

Table 8: Product Portfolio - BD

Table 9: Company Profile - Boston Scientific

Table 10: Boston Scientific SWOT Analysis, 2016

Table 11: Product Portfolio - Boston Scientific

Table 12: Company Profile - Cook Medical

Table 13: Cook Medical, SWOT Analysis, 2016

Table 14: Product Portfolio - Cook Medical

Table 15: Company Profile - C. R. Bard

Table 16: C. R. Bard, SWOT Analysis, 2016

Table 17: Product Portfolio - C. R. Bard

Table 18: Company Profile - Gallini Medical Devices

Table 19: Gallini Medical Devices SWOT Analysis, 2016

Table 20: Product Portfolio - Gallini Medical Devices

Table 21: Company Profile - Hologic

Table 22: Hologic SWOT Analysis, 2016

Table 23: Product Portfolio - Hologic

Table 24: Company Profile - Leica Biosystems

Table 25: Leica Biosystems, SWOT Analysis, 2016

Table 26: Product Portfolio - Leica Biosystems

Table 27: Company Profile - Stryker

Table 28: Sktryker SWOT Analysis, 2016

Table 29: Product Portfolio - Stryker

Table 30: Company Profile - TSK Laboratory

Table 31: TSK Laboratory SWOT Analysis, 2016

Table 32: Product Portfolio - TSK Laboratory

Table 33: Company Profile - Zamar Care

Table 34: Zamar Care SWOT Analysis, 2016

Table 35: Product Portfolio - Zamar Care

Table 36: Emerging Players in Liquid Biopsy Market

Table 37: Global Biopsy Procedure Volume, 2013-2022

Table 38: Age Demographics, Age >65 Years, Global, 2013

Table 39: Global FNA Device Sales ($m) Forecast, 2013-2022

Table 40: Global CNB Device Sales ($m) Forecast, 2013-2022

Table 41: Global VAB Device Sales ($m) Forecast, 2013-2022

Table 42: Global Biopsy Guns Sales ($m) Forecast, 2013-2022

Table 43: Global Biopsy Forceps and Punches Sales ($m) Forecast, 2013-2022

Table 44: Global Biopsy Devices Sales ($m) Forecast, 2013-2022

Table 45: Global Biopsy Devices Sales Unit, 2013-2022

Table 46: Global Biopsy Devices Sales Unit by device type, 2013-2022

Table 47: US Biopsy Devices Sales ($m) Forecast, 2013-2022

Table 48: France Biopsy Devices Sales ($m) Forecast, 2013-2022

Table 49: Germany Biopsy Devices Sales ($m) Forecast, 2013-2022

Table 50: Italy Biopsy Devices Sales ($m) Forecast, 2013-2022

Table 51: Spain Biopsy Devices Sales ($m) Forecast, 2013-2022

Table 52: UK Biopsy Devices Sales ($m) Forecast, 2013-2022

Table 53: Japan Biopsy Devices Sales ($m) Forecast, 2013-2022

Table 54: Brazil Biopsy Devices Sales ($m) Forecast, 2013-2022

Table 55: China Biopsy Devices Sales ($m) Forecast, 2013-2022

Table 56: India Biopsy Devices Sales ($m) Forecast, 2013-2022

1.2 List of Figures

Figure 1 : Biopsy Devices, Global Market Share, 2015

Figure 2: VAB, Global Market Share, 2015

Figure 3: CNB/FNA, Global Market Share, 2015

Figure 4: Global Biopsy Procedure Volume: All Indications, 2013-2022

Figure 5: Biopsy Procedure Volume: All Indications, US, 2013-2022

Figure 6: Biopsy Procedure Volumes: Prostate, 5EU, 2013-2022

Figure 7: Biopsy Procedure Volume: Breast, 5EU, 2013-2022

Figure 8: Biopsy Procedure Volume: Lung, 5EU, 2013-2022

Figure 9: Biopsy Procedure Volume: Colorectal, 5EU, 2013-2022

Figure 10: Biopsy Procedure Volumes: Liver, 5EU, 2013-2022

Figure 11: Biopsy Procedure Volume: Thyroid, 5EU, 2013-2022

Figure 12: Biopsy Procedure Volume: Prostate, APAC Region, 2013-2022

Figure 13: Biopsy Procedure Volume: Breast, APAC Region, 2013-2022

Figure 14: Biopsy Procedure Volume: Lung, APAC Region, 2013-2022

Figure 15: Biopsy Procedure Volume: Colorectal, APAC Region, 2013-2022

Figure 16: Biopsy Procedure Volume: Liver, APAC Region, 2013-2022

Figure 17: Biopsy Procedure Volume: Thyroid, APAC Region, 2013-2022

Figure 18: Biopsy Procedure Volume: All Cancer Indications, Brazil, 2013-2022

Figure 19: Global FNA Device Sales ($m) Forecast, 2013-2022

Figure 20: Global CNB Device Sales ($m) Forecast, 2013-2022

Figure 21: Global VAB Device Sales ($m) Forecast, 2013-2022

Figure 22: Global Biopsy Guns Sales ($m) Forecast, 2013-2022

Figure 23: Global Biopsy Forceps and Punches Sales ($m) Forecast, 2013-2022

Figure 24: Global Biopsy Devices Sales ($m) Forecast, 2013-2022

Figure 25: Global Biopsy Devices Sales ($m) share by country, 2015 and 2022

Figure 26: US Biopsy Devices Sales ($m) Forecast, 2013-2022

Figure 27: France Biopsy Devices Sales ($m) Forecast, 2013-2022

Figure 28: Germany Biopsy Devices Sales ($m) Forecast, 2013-2022

Figure 29: Italy Biopsy Devices Sales ($m) Forecast, 2013-2022

Figure 30: Spain Biopsy Devices Sales ($m) Forecast, 2013-2022

Figure 31: UK Biopsy Devices Sales ($m) Forecast, 2013-2022

Figure 32: Japan Biopsy Devices Sales ($m) Forecast, 2013-2022

Figure 33: Brazil Biopsy Devices Sales ($m) Forecast, 2013-2022

Figure 34: China Biopsy Devices Sales ($m) Forecast, 2013-2022

Figure 35: India Biopsy Devices Sales ($m) Forecast, 2013-2022
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Argon Medical Devices
  • Boston Scientific
  • C. R. Bard
  • Cook Medical
  • Gallini Medical Devices
  • Hologic
  • MORE
Global Biopsy Devices Market Value to Grow Moderately by 2019, with Emerging Countries Increasing their Shares, says The authors

The global biopsy devices market value will increase at a modest rate over the coming years, climbing from $506.4 million in 2013 to $602.4 million by 2019, at a Compound Annual Growth Rate (CAGR) of 2.93%, forecasts research and consulting firm The authors.

According to the company’s latest report*, the biopsy devices market in emerging economies, such as China, India and Brazil, will increase at much higher CAGRS than the global rate, reaching shares of 24%, 10% and 6% by 2019, respectively.

Despite the modest global growth, several barriers are dampening the potential adoption of biopsy devices within a number of markets. Notably in the US, reimbursement for image-guided breast biopsies has undergone drastic cuts, which The authors expects will have a significant effect on the adoption of more expensive vacuum-assisted biopsy (VAB) devices.

Joseph Gregory, The authors’s Analyst covering Surgical Devices, says: “Additionally, routine screening for prostate cancer and breast cancer has come under scrutiny, as sophisticated clinical trials reveal that these interventions have a minimal impact on the cancer related mortality. This is a long-term setback for the adoption of biopsy devices in diagnosing these cancers, given that these criticisms could curb adoption of routine screening.”

While these challenges are likely to affect the biopsy devices market, The authors believes that current and future players can still position themselves to obtain a competitive advantage.

“The major European countries have general mass-screening programs for breast cancer detection and will be increasing their adoption of VAB devices over the forecast period. Additionally, the emerging economies are increasing their access to healthcare resources and showing a preference for more expensive core needle biopsy devices over fine needle aspiration devices,” Gregory concludes.

*MediPoint: Biopsy Devices - Global Analysis and Market Forecasts

This report and forecast focuses on the adoption patterns of surgical biopsies, fine needle aspiration (FNA) devices, core needle biopsy (CNB) devices, and vacuum-assisted biopsy (VAB) devices in the diagnosis of breast, prostate, lung, liver, and thyroid cancers. Countries covered include the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China, and India.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by The authors’s team of industry experts.
Note: Product cover images may vary from those shown
5 of 6
Argon Medical Devices
Becton, Dickinson and Company
Boston Scientific
Cook Medical
C. R. Bard
Gallini Medical Devices
Hologic
Leica Biosystems
Stryker
TSK Laboratory
Zamar Care
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll